Novellus Systems Enhances Singapore DRAM Manufacturer Productivity and Performance

Novellus Systems, Inc., announced that its VECTOR Express™ plasma enhanced chemical vapor deposition (PECVD) system has been successfully qualified for production at TECH Semiconductor. The Singapore based DRAM manufacturer has selected VECTOR Express for its productivity enhancements, low defectivity and high yield at 300 mm.

The shipment also marks a major milestone in Novellus’ rapid growth in the Southeast Asia market — this is the 100th 300 mm tool from Novellus to be placed in the region.

The unparalleled productivity demonstrated by VECTOR Express has helped TECH Semiconductor continuously drive down cost of ownership in the challenging DRAM market place”, said Andrew Goh, president of Novellus’ Southeast Asia operations. “TECH is pleased with Novellus’ responsiveness and our commitment to improve productivity for a variety of applications including AHM, TEOS, SiN and SiON films.”

According to SEMI, the wafer processing equipment market in Southeast Asia is expected to grow at a rate of more than 7 percent in 2008.  Singapore in particular continues to be a high-growth area for semiconductor manufacturing, with the addition of several new fabs and the expansion of existing ones.

“Southeast Asia is expected to be a growth region for semiconductor manufacturing in the coming years - driven largely by memory manufacturers,” said Tom Caulfield, executive vice-president of sales, marketing and customer service at Novellus. “Our focus has always been on providing the highest value in capital productivity to our customers and introducing the VECTOR Express into this region is another example to our goal of meeting our customers’ need for tools with lower cost of ownership.
 

Posted March 13th,2008

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.